Basic info
Industry
biotechnology research
Sectors
Biotechnology
Licensing/Distribution
Artificial Intelligence
Oncology
Digital Healthcare
Personalized Medicine
Clinical Development
Pharmaceutical
Machine Learning
Health Care
Dosage Optimization
Therapeutics
Infectious Diseases
Drug Development
Biopharma
Life Science
Pharmaceuticals
Date founded
2016
Funding rounds raised
Total raised
$5M
from 2 investors over 2 rounds
K
KYAN Therapeutics raised $5M on October 26, 2022
Investors: Altara Ventures and K3 Ventures